You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Yttrium-90

Showing 1 - 25 of 5,556
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Yttrium-90 carbon microspheres SIRT
  • Nanjing, China
    Gao-Jun Teng
Jul 20, 2023

Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

Recruiting
  • Unresectable Colorectal Liver Metastases
  • Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jan 26, 2023

Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)

Recruiting
  • Thrombocytopenia
  • Cirrhosis
  • TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Sep 7, 2022

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Active, not recruiting
  • Advanced Adult Primary Liver Cancer
  • +3 more
  • positron emission tomography
  • computed tomography
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Inoperable Hepatocellular Carcinoma Trial in Nanjing (TheraSphere™ Yttrium-90 Glass Microspheres, conventional Transarterial

Recruiting
  • Inoperable Hepatocellular Carcinoma
  • TheraSphere™ Yttrium-90 Glass Microspheres
  • conventional Transarterial Chemoembolization(cTACE)
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jul 22, 2022

Hepatic Malignancies Trial in Cleveland (PET/CT, PET/MR, SIRT with Y-90)

Completed
Has Results
  • Hepatic Malignancies
  • PET/CT
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jun 1, 2022

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))

Completed
  • Liver Cancer
  • Hepatoma
  • Yttrium 90 (TheraSphere)
  • (no location specified)
Sep 28, 2022

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab and Bevacizumab
  • Y90 + TKI
  • Chicago, Illinois
    Northwestern University
Nov 11, 2022

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))

Not yet recruiting
  • Colorectal Neoplasms
  • Resin microspheres containing yttrium-90 (Y-90)
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023

Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial in Portland

Not yet recruiting
  • Hepatocellular Carcinoma
  • +8 more
  • Quality of Life
  • +3 more
  • Portland, Oregon
  • +1 more
Jun 20, 2022

HCC Trial in Bologna (Personalized dosimetry approach, Standard dosimetry approach)

Recruiting
  • HCC
  • Personalized dosimetry approach
  • Standard dosimetry approach
  • Bologna, Italy
    IRCCS Azienda Ospedaliero-Universitaria di Bologna
Jan 26, 2022

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Cholangio Carcinoma Trial in Hong Kong (SIRT Yttrium-90)

Active, not recruiting
  • Cholangio Carcinoma
  • SIRT Yttrium-90
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
May 3, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Stage IV Uveal Melanoma Trial in Philadelphia (Sir-Spheres®)

Active, not recruiting
  • Stage IV Uveal Melanoma
  • Sir-Spheres®
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 20, 2022

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023